LAPTM4A and glioblastoma: Similarly, overexpression of LAPTM4A was associated with unfavorable OS (p = 1.1 e-6) and DSS (p = 1.5 e-6), and PFI (p = 4.8 e-6) in LGG (Figure 3D–3F), and correlated with poor OS (p = 0.03) and DSS (p = 0.03) and PFI (p = 0.02) in GBM (Figure 3G–3I).